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Cross-species analysis across 450 million years of evolution reveals conservation and 1 
divergence of the microglia program 2 
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SUMMARY 34 
 35 
Microglia, the brain-resident immune cells, are critically involved in many physiological and 36 
pathological processes, including neurodegeneration. Here we characterize microglia 37 
morphology and transcriptional program across ten species spanning more than 450 million 38 
years of evolution. We find that microglia express a conserved core gene program of 39 
orthologous genes from rodents to human, including ligands and receptors associated with 40 
interactions between glia and neurons. In most species, microglia show a single dominant 41 
transcriptional state, while human microglia display significant heterogeneity. In addition, we 42 
observed notable differences in several gene modules of rodents as compared to primate 43 
microglia; including complement, phagocytic and susceptibility genes to neurodegeneration, 44 
such as Alzheimer’s and Parkinson’s disease. Our study provides an essential resource of 45 
conserved and divergent microglia pathways across evolution with important implications for 46 
future development of microglia-based therapies in humans. 47 
Manuscript
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INTRODUCTION 48 
 49 
Microglia are the primary resident immune cells of the central nervous system (CNS) 50 
parenchyma and are seeded during development from mesodermal progenitors (Alliot et al., 51 
1999; Ginhoux et al., 2010; Kierdorf et al., 2013; Perdiguero et al., 2014). Lineage tracing 52 
studies using mice have demonstrated that they can persist in the brain through local self-53 
renewal, with no significant replenishment of monocytes during homeostatic conditions (Ajami 54 
et al., 2011; Askew et al., 2017; Hashimoto et al., 2013; Tay et al., 2018; Yona et al., 2013). 55 
They can rapidly repopulate their niche by self-renewal if depleted (Bruttger et al., 2015; Najafi 56 
et al., 2018), showing their unique adaptation to the brain parenchyma. This brain-specific 57 
tissue environment induces functional specialization of microglia resulting in a highly distinct 58 
phenotype separate from other tissue macrophage populations (Gosselin et al., 2014; Lavin et 59 
al., 2014). Additionally, microglia have been shown to be susceptible to environmental stimuli, 60 
such as microbiome and neonatal infections (Erny et al., 215; Thion et al., 2018). 61 
 62 
Depending on the brain region, microglia are estimated to compose 5-20% of all brain cells, 63 
(Lawson et al., 1990; Perry, 1998). Microglia shape important brain processes such as neuronal 64 
pruning and development (Parkhurst et al., 2013; Schafer et al., 2012). Importantly, innate 65 
immune activation is considered to be of a critical pathophysiologic significance in most 66 
neurodegenerative diseases such as Alzheimer’s disease (AD), suggesting microglia as central 67 
players in disease pathology (Matcovitch-Natan et al., 2016). Recently, we and others have 68 
demonstrated that microglia specific pathways, such as Trem2-Tyrobp and ApoE are critical 69 
determinants in AD and other neurodegenerative diseases (Jansen et al., 2019; Lambert et al., 70 
2013; Keren-Shaul et al., 2017). Incidences of neurodegenerative disorders have steadily 71 
increased over the last decades in line with higher life expectancies of humans (Drew, 2018). 72 
Despite immense efforts over the past decades to find a cure for neurodegenerative disorders 73 
using transgenic animal models, large differences are observed in multiple characteristics of 74 
disease manifestation in human versus animal models. A better understanding of the conserved 75 
and divergent pathways of microglia may highlight the impact and limitation of commonly used 76 
animal models for neurodegeneration.  77 
 78 
Large-scale sequencing of animal genomes has paved the way for characterization of genomic 79 
elements that are highly conserved across millions of years of evolution (La Manno et al., 2016; 80 
Suryamohan and Halfon, 2015). However, major challenges remain when applying this for 81 
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analysis of gene expression conservation across cell types. Standard antibody-based cell type 82 
purification across species remains challenging, as epitope and antibody differences and 83 
impurities of the cell population captured with these antibodies across different species 84 
significantly restrict accurate cross-species analysis (Giladi and Amit, 2018). Potentially, 85 
single-cell RNA-sequencing (scRNA-seq) can overcome these challenges, bypassing the need 86 
for pure cell sorting strategies. Accordingly, scRNA-seq has been used to deconvolve immune 87 
cell type heterogeneity by identifying novel distinct immune cell subsets in health and diseases 88 
(Jaitin et al., 2014; Keren-Shaul et al., 2017; Papalexi and Satija, 2018; Paul et al., 2016; Jaitin 89 
et al., 2019; Li et al., 2019), and provided new insights into the development and evolution of 90 
cell types (La Manno et al., 2016; Pollen et al., 2015; 2014; Sebé-Pedrós et al., 2018; Treutlein 91 
et al., 2014; Zeisel et al., 2015).  92 
 93 
Here, we comprehensively characterize the conservation and divergence of the microglia 94 
program across evolution. By comparing microglia gene expression across species, we identify 95 
a conserved microglia core program in all mammals. Single cell analysis showed that most 96 
mammalian microglia display one primary transcriptional state without any other apparent 97 
subtypes. However, predominantly in humans, we observed substantial microglial 98 
heterogeneity, with subtypes of microglia transcriptional signatures that are common to all 99 
individuals examined. Importantly, microglia also contained species- and clade-specific gene 100 
expression pathways associated with the complement system, phagocytosis and metabolic 101 
pathways. By cross-comparing the microglia gene-expression with genome wide association 102 
studies (GWAS) of human neurodegenerative diseases, we observed significant expression 103 
changes of susceptibility genes for AD and Parkinson's disease (PD) in primates and humans 104 
compared to rodents. In summary, we show the importance of cross evolutionary comparison 105 
to better characterize human-specific microglia pathways and the relevance of these to human 106 
disease. Our data offers an essential resource for the neuroimmunology community to move 107 
forward towards the development of immunotherapy-based treatments for neurodegenerative 108 
and neurodevelopmental disorders.   109 
  110 
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RESULTS  111 
 112 
Parenchymal microglia display a conserved morphological pattern across evolution 113 
To determine microglia conservation across evolution, we collected brain tissue of eighteen 114 
evolutionary distant species for detailed microscopical analysis (Figure 1A). We identified 115 
microglia using ionized calcium binding adaptor molecule 1 (Iba1), a prototypical marker for 116 
microglia, perivascular macrophages, and monocytes of human, rats and, mice (Prinz and 117 
Priller, 2014) that has been traditionally used to identify microglia within the parenchyma, as 118 
other glial cells and neurons do not express it. Iba1 immunohistochemistry-based 3D-Imaris 119 
analysis revealed that 16 of the 18 animals were positive for parenchymal Iba+ cells, whereas 120 
chicken and zebrafish were not (Figure 1B). The pan-myeloid markers mPEG1 (mPEG1-GFP 121 
zebrafish) (Ellett et al., 2011) and CSF1R (CSF1R-mApple chickens) (Balic et al., 2014) were 122 
subsequently used for myeloid identification within the parenchyma of these species (Figure 123 
1B). Microscopic analysis of Iba1+, mPEG+ and CSF1R+ parenchymal myeloid cells showed 124 
cells with typical microglial morphology including, spindle-shaped soma and a distinct 125 
arborization pattern as described before (Sierra et al., 2016) (Figure 1B and S1A). The 126 
distinctive morphology and widespread distribution of these cells were highly consistent with 127 
the classical descriptions of ramified microglia. These findings suggest that CNS parenchymal 128 
cells with microglia-like features and markers can be found across all these animals, although 129 
we observed a considerable range of ramification and cell sizes between species (Figure 1B 130 
and S1A). Analysis of mouse and human microglial morphology revealed a partial region-131 
specific heterogeneity in both species, including smaller dendrite length, smaller number of 132 
segments, and fewer branch points and terminal points in the molecular layer of the cerebellum 133 
(Figure S1B-C). In general, the overall morphology of human microglia showed the highest 134 
similarity to macaque, mouse, rat, hamster, sheep, boar, bat and chicken microglia in terms of 135 
dendrite length, number of branching segments, terminal points and volume (Figures 1B-G 136 
and S1A). The highest microglial density was detected in leech ganglia with 299.0 ± 41.4 Iba1+ 137 
microglia per mm² and lowest microglial numbers in axolotl (11.1 ± 0.7 per mm²) (Figures 1H-138 
I). 139 
 140 
We quantified the number of neurons in the cortex (Figure 1J) and neurons per microglia 141 
(Figure 1K). In correlation analysis, we detected positive correlation of microglial density per 142 
mm² and microglia process length across species (Figure S1D), whereas we did not observe 143 
any detectable correlation between microglial and neuronal density (Figure S1E) or 144 
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microglia/neuron ratio and microglia process length (Figure S1F). In line with previous reports 145 
(Menassa and Gomez-Nicola, 2018), we detected a higher microglial density in the frontal 146 
cortex of mice (65.8 ±1.09 cells/mm2) compared to human frontal cortex (35.5 ±2.48 147 
cells/mm2), and more microglia in the human cerebellum (molecular layer), hippocampus and 148 
white matter compared to the respective regions in mice (Figure S2A-D). In summary, 149 
histological analysis shows that microglial density varies markedly across the species even 150 
among rodents and larger mammals. Further, while microglia display typical and conserved 151 
morphology, the degree of ramification and cell size differs considerably in many of the species 152 
examined. 153 
 154 
Characterization of the microglia gene expression program across species 155 
To better understand the divergence and conservation of the microglia gene expression across 156 
evolution, we collected brains from three to six individuals for the eight species that had a high-157 
quality reference genome: human, macaque, marmoset, sheep, mouse, hamster, chicken and 158 
zebrafish. Since even carefully sorted samples for bulk RNA-seq contain contaminating cells, 159 
and scRNA-seq may potentially not be sensitive enough for detection of lowly expressed genes, 160 
we used a combined single cell and bulk RNA-seq strategy to characterize the microglia gene 161 
program across evolution (Figure 2A; STAR Methods). Analysis of the single cell data was 162 
then used to deconvolute the bulk RNA-seq data and remove contaminating genes (Figure 2A; 163 
STAR Methods) (Baron et al., 2016).  164 
 165 
In order to preserve the in situ transcriptional state of microglia, all samples were freshly 166 
processed and FACS sorted using a highly conserved pan immune marker; Protein tyrosine 167 
phosphatase, receptor type C (Ptprc/ CD45; Figure S3A) (Holmes, 2006; Nagata et al., 2002; 168 
Okumura et al., 1996). Cells were sorted for massively parallel single-cell RNA sequencing 169 
(MARS-seq2.0) analysis (Jaitin et al., 2014; Keren-Shaul et al., 2019) or for bulk RNA 170 
sequencing (Figure 2A). We collected a total of 4458 quality controlled (QC) -positive 171 
microglia cells from eight species as well as three to six bulk RNA-seq samples for each species 172 
(Figure S3B-D and Table S1). The Metacell  algorithm (Baran et al., 2018; Giladi et al., 2018) 173 
was used to identify homogeneous and robust groups of cells (“Metacells”; STAR Methods). 174 
The majority of immune cells in the examined species were identified as microglia based on 175 
their gene signature. Nonetheless, most species contained some metacells that were identified 176 
as contaminating cells (Table S1). For example, in chicken, analysis of CD45+ brain cells 177 
revealed two major groups of immune populations (Figure 2B). The first group expressed the 178 
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microglia gene signature, including multiple typical microglia markers that have already been 179 
identified in human and mice microglia (e.g., SALL1, P2RY12, C1QB; Figure 2B), while the 180 
second group expressed marker genes associated with T cells (e.g. CD3E, RORA and IL7R) 181 
(Figure 2B). In order to focus on the microglia cells, after identification of contaminating cell 182 
clusters, we removed the genes associated with these clusters from the bulk RNA-seq data 183 
(Figure 2C-D, S3E; STAR Methods). We applied this method of microglia single cell 184 
characterization and bulk RNA-seq deconvolution data analysis to all species. Together, these 185 
findings highlight the potential of scRNA-seq to define with minimal biases conserved cell type 186 
transcriptional signature across species, enabling a marker-free molecular comparison of the 187 
microglia program across evolution.    188 
 189 
Microglia express a core gene program across evolutionary distant species 190 
To compare gene expression across species, we first defined a set of homologous genes across 191 
species. We used a “meta-gene” strategy to solve the one-to-many and many-to-many 192 
relationships of orthologues that have changed in evolution through duplication/deletion events 193 
(STAR Methods). Orthologue conjecture is widely accepted as a method to pair genes over 194 
evolution as orthologues diverge slowly, most explicitly in a tissue-specific manner, whereas 195 
paralogs do not (Kryuchkova-Mostacci and Robinson-Rechavi, 2016). After filtering for lowly 196 
expressed genes, we identified 8890 genes that were expressed in microglia of at least one of 197 
the species (STAR Methods). Gene quantile normalization, followed by clustering analysis of 198 
the deconvoluted bulk and scRNA-seq of microglia across evolution, identified 17 prominent 199 
gene clusters (Figure 3A and S4A; STAR Methods). These clusters include a microglia core 200 
signature expressed in all species (Clusters 1-10), but to a lesser extent in the zebrafish and 201 
chicken, as well as clade and species-specific programs (Clusters 11-17; Figure 3A and S4A). 202 
Hierarchical clustering across samples grouped the species based on their evolutionary distance 203 
and displayed two major groups with the zebrafish and chicken microglia forming an outgroup 204 
from the mammals (Figure 3A). This was not affected by the number of clusters or analysis 205 
method and similar results were seen when applying principal component analysis (PCA; 206 
Figure S4B). Macaque showed the highest similarity in expression patterns to human microglia 207 
while laboratory mouse strains clustered together with wild mice and hamster (Figure 3A and 208 
Figure S4A-E, Table S3; STAR Methods).  209 
 210 
The transcription factors Spi1 and Irf8 have been shown to be the core orchestrators for 211 
microglia development (Hoeffel et al., 2015; Kierdorf et al., 2013). Tgfb2r and Csf1r have also 212 
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been demonstrated to play an essential signaling role in microglia development, where the 213 
absence of these genes or inhibition of their signaling shows marked reduction or complete 214 
absence of microglia (Butovsky et al., 2014; Cronk et al., 2018; Elmore et al., 2014; 215 
Matcovitch-Natan et al., 2016; Pridans et al., 2018). CSF1R mutations also reduce microglia 216 
numbers in the human brain (Colonna and Butovsky, 2017). Consistent with these results, we 217 
observed strong conservation and expression of Spi1, Irf8, Csf1r, and Tgfb2r across all species, 218 
supporting the idea of the central role of these factors in microglia biology (Figure 3A-B, and 219 
S4C). Lysosomal hydrolases (e.g. Cst3, Ctsa, Ctss, Ctsb, Ctsh, Ctsc, Ctsz, and Hexa) were 220 
observed to be both highly expressed and conserved across mammalian species. Several of them 221 
are ubiquitously expressed in macrophages (e.g. Ctsb, Ctsh, Ctsc), but others have more 222 
restricted tissue expression, and their absence (e.g. Ctsa and Hexa) can cause severe 223 
neurological phenotypes (Caciotti et al., 2013). Another highly expressed and conserved 224 
lysosomal gene Grn (or progranulin), has been implicated in frontotemporal dementia in 225 
humans and mice (Baker et al., 2006). 226 
 227 
Microglia genes that have been previously linked to the homeostatic gene signature of microglia 228 
are both highly expressed and conserved in all species, including C1qc, P2ry12 and Tardbp 229 
(Figure 3B-C and S4C). Tardbp was recently shown to be protective against synapse loss in 230 
an AD mouse model, whereas its absence promoted higher amyloid clearance by enhancing 231 
phagocytosis (Paolicelli et al., 2017). Vsir (or VISTA) is an immune checkpoint gene, which 232 
inhibits T-cell response (Xu et al., 2018) and is highly conserved in all microglia (Figure 3C 233 
and S4C). Its expression has been shown to be increased in several neurological diseases, such 234 
as AD (Borggrewe et al., 2018). Interestingly, previously identified markers for yolk-sac 235 
derived microglia (e.g., Daglb, Bin1, Cst3, Sall1, Prpsap2, Entpd1, Tmem119, P2ry12, and 236 
CD81; Figure 3B-C and S4C) were present in core microglia clusters 1-3. These genes are 237 
highly enriched in microglia, and are not upregulated in monocytes that engraft the brain in 238 
microglial-depleted mouse models (Bennett et al., 2018; Cronk et al., 2018; Shemer et al., 239 
2018).  240 
 241 
Many of the conserved microglia genes in clusters 1-3 are shared by other tissue macrophages, 242 
which underlines the sentient role of the microglia/macrophage as phagocytic and defense cells 243 
in multicellular organisms (Figure S4F and Table S4).  In order to identify the conserved 244 
microglia specific genes, we next compared our cross-species core signature (Clusters 1-3) to 245 
previously published datasets of a large compendium of mouse tissue-macrophages (Lavin et 246 
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al., 2014). This was done with the aim to discover highly conserved and cross-species genes 247 
specific for microglia but not to other tissue macrophages (Lavin et al., 2014). Our cross-species 248 
analysis identified 163 genes that are both conserved and unique to microglia (Figure 3D and 249 
Table S4; Lavin et al., 2014). Among them is Adgrg1 (Gpr56), previously demonstrated to be 250 
conserved in human, mouse, and zebrafish, but also implicated in the development of 251 
oligodendrocytes (Giera et al., 2018). Another conserved microglial gene is amyloid β 252 
precursor protein-binding family b member 1 interacting protein (Apbb1ip) (Figure 3D), a 253 
binding partner of the amyloid precursor protein (APP), Tau, 14-3-3γ, and glycogen synthase 254 
kinase 3 β (GSK3 β). We further identified brain-specific functions, for example regulation of 255 
neuron projection development and cerebellum development, as the most enriched gene 256 
ontology pathways associated with these microglial specific genes (Figure S4G). These results 257 
indicate that microglia express a large set of conserved core genes across all mammalian 258 
species, including genes relevant for general tissue macrophage functions as well as microglia 259 
specific CNS adaptations. In addition, we could confirm two of those markers, P2RY12 and 260 
PU.1 by histology in several animals (Figure S5A and S5B, respectively).  261 
 262 
Single-cell transcriptomic analysis identifies human microglia subsets 263 
In order to examine whether the microglia of each specie display a homogenous cell type or 264 
contain several subtypes, we further analyzed the microglia single cell data to evaluate 265 
microglia heterogeneity for each mammalian species. We first clustered microglia cells from 266 
each species separately and compared the intra- versus inter-cluster correlation to evaluate 267 
whether there is a clear separation of microglia sub-types or a continuum of a single population 268 
(Figure 4A). Surprisingly, we observed low inter-cluster correlation in all human samples 269 
compared to intra-clusters (Figure 4A). Cell-to-cell correlation analysis revealed that microglia 270 
from all human individuals are organized into several microglia-types (Figure 4B), which 271 
confirms previous reports (Masuda et al., 2019). This was in sharp contrast to mouse (Figure 272 
4C), macaque (Figure S6A), marmoset (Figure S6B), hamster (Figure S6C), and sheep 273 
(Figure S6D), which show high intra-cluster correlation and predominantly one dominant 274 
microglia type. Probing the heterogeneity of human microglia, we observed a sub-population 275 
with increased expression of several inflammatory genes that have been linked with a 276 
senescence-associated secretory phenotype (SASP) (Kobbe, 2018) (Figure 4D), without any 277 
change of homeostatic gene expression (Figure 4D). This inflammatory signature of potentially 278 
senescent-like microglia has been identified in most tissues of all ages in human and mice but 279 
their number increases with age (He and Sharpless 2017). These cells are implicated in sterile 280 
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inflammation, wound healing, and age-related processes, including neurodegeneration (Bussian 281 
et al., 2018).  Further investigation of these putative senescent-like microglia revealed that they 282 
were not specific to a single individual, but were consistent across all six sampled individuals, 283 
comprising roughly 20% of all microglia (Figures 4E). This microglia subset consistently co-284 
expressed CDKN1, CCL3, CCL4, CCL3L3 and CCL4L2 (Figures 4F) along with higher 285 
expression of inflammatory cytokines such as TNF and IL1B (Figure 4B, 4D). This signature 286 
was not observed in young-adult mouse microglia (Figure 4C), but inflammatory cytokines 287 
have been previously seen in a sub-set of microglia in aged C57Bl/6 mice (Hammond et al., 288 
2019; Sierra et al., 2007; Mrdjen et al., 2017).  289 
 290 
A potential source of human microglia heterogeneity may involve interaction with the non-291 
sterile environment. However, we did not observe microglia heterogeneity in wild mice (Figure 292 
S6E). Laboratory mouse models have been described to show considerable differences 293 
regarding the immune system regulation (Sellers et al., 2012).  However, the microglia 294 
expression program of all mouse strains showed high similarity to each-other (Figure S6F), 295 
and only a small number of genes were identified as differential between the mouse strains 296 
(Figure S6G) Furthermore, comparing non-challenged microglia from four laboratory mouse 297 
strains housed in a specific pathogen free (SPF) facility, with wild mice housed in a non-SPF 298 
facility (including pathogens that are present in a natural environment), revealed only few 299 
differences (Figure S6H). In summary, single-cell transcriptomic analysis identifies major 300 
microglia heterogeneity in humans, in contrast to other mammals that mostly display a single 301 
microglia type in steady state, under non-pathological conditions. 302 
 303 
Interspecies comparison identifies divergence in metabolic and immune pathways 304 
In order to better understand the conservation of genes associated with neurodegenerative 305 
diseases, we have expanded our transcriptome analysis to include additional commonly studied 306 
rodent models: the rat (Rattus norvegicus), and the long-lived blind mole rat (BMR, Spalax 307 
ehrenbergi; maximum life-span of 20.2 years) (Figure S7A-B). Pairwise comparison of human 308 
microglia scRNA-seq transcriptomic data to rodents, identified a large module of differentially 309 
expressed genes (S7A-B and Table S5). In contrast, we observed a considerably smaller 310 
number of differentially expressed genes between human and macaque microglia, with most of 311 
the differentially expressed genes related to metabolic pathways such as NAD kinase (NADK; 312 
soluble vitamins metabolism) and beta-carotene oxygenase 2 (BCO2; carotenoid oxidization) 313 
(Figure 5A).  314 
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 315 
Pathway analysis of clusters specific to humans, macaque, marmoset, and sheep compared to 316 
rodents revealed enrichment of DNA repair pathways (Figure S7D), which have been 317 
previously implicated in longevity (Ungavari et al., 2008). Additionally, enriched pathways 318 
included phagocytosis (Figure S7E), more specifically apoptotic cell clearance (Figure S7F 319 
and Table S6) and the complement pathway (Star Methods; Figure S7G and Table S6). 320 
Several other pathways were enriched in all tested mammals except mice, in particular negative 321 
regulation of the ferroptosis pathway (Figure S7H). Ferroptosis is a newly described form of 322 
cell death driven by loss of activity of the lipid repair enzyme glutathione peroxidase 4 (GPX4) 323 
and subsequent accumulation of lipid-based reactive oxygen species (ROS), along with 324 
cytosolic accumulation of iron. Interestingly, several of those cellular events, including defects 325 
in phagocytosis, are thought to be hallmark drivers of many neurodegenerative diseases, 326 
including AD and PD. 327 
 328 
Conservation and divergence of microglia neurodegenerative related pathways  329 
Rodent animal models are critical for our understanding of many physiological and disease 330 
mechanisms. However, successful translation from neurodegenerative animal models to human 331 
clinical trials is far from adequate (Doody, 2017; Sperling et al., 2014; Vellas et al., 2014). In 332 
order to better understand the conservation of microglia genes associated with 333 
neurodegenerative diseases, we compared human microglia to commonly used animal models. 334 
We compared the gene expression of neurodegenerative disease susceptibility genes from 335 
GWAS studies of human microglia as compared to the other mammalian species (STAR 336 
methods; Figure 5B). Expression of Parkinson and Alzheimer’s disease associated genes in 337 
human microglia showed highest correlation with macaque (PD, r = 0.73; AD, r = 0.59) (Figure 338 
5B). In contrast, mice, rats and hamsters showed moderate to low correlation of AD and PD 339 
susceptibility genes to humans (r = 0.16 - 0.40) (Figure 5B). We observed significant over-340 
representation for PD genes in the human specific cluster and clusters shared by human and 341 
macaques (Figure S8A). Conversely, we did not see any significant enrichment nor depletion 342 
of genes from GWAS studies of Schizophrenia or Huntington disease in any animal (Figure 343 
5B and S8C-D). Human and macaque specific susceptibility genes included Msr1 (macrophage 344 
scavenger receptor 1) (Figure 5C and S8G). Msr1 mediates endocytosis of low density 345 
lipoproteins (LDL) and is involved in uptake and degradation of amyloid b (Aβ) (Frenkel et al., 346 
2013). Previously, genes expressed by microglia have been implicated in AD in human 347 
genome-wide association studies (Gandal et al., 2018; Jansen et al., 2019; Keren-Shaul et al., 348 
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2017). However, this is the first study identifying specific enrichment of AD and PD 349 
susceptibility genes in microglia and their expression across evolution (Figure S8A-B and E-350 
G). In summary, our analysis identifies marked evolution in the expression of multiple 351 
microglia pathways involved in metabolic, complement and phagocytic pathways, with many 352 
of these pathways implicated in neurodegenerative diseases.   353 
  354 
DISCUSSION  355 
 356 
Effective development of therapies for neurodegenerative diseases is limited. This could be due 357 
to the complexity of the CNS or potentially from lack of molecular understanding of relevant 358 
animal models. In the current study, we systematically and comprehensively characterized 359 
microglia from ten species of varying evolutionary distance, using a combination of single-cell 360 
genomic technologies and histological analysis. We observed conservation of mammalian 361 
microglia gene expression program, suggesting that microglia perform overall similar functions 362 
throughout mammalian evolution. This is in accordance with previous reports showing high 363 
constraints of brain gene expression-variance across evolution (Chan et al. 2009; Brawand et 364 
al. 2011; Chen et al. 2019). Nevertheless, a substantial number of species-specific gene 365 
expression was observed, which exhibited enrichment of several pathways that have not been 366 
related to microglia or human microglia before. Our analysis of human, macaque and marmoset 367 
revealed higher expression of pathways that have been implicated in longevity and anti-368 
inflammatory responses; more specifically - DNA repair pathways, negative regulation of 369 
ferroptosis and apoptotic cell clearance. Many hallmarks of human neurodegeneration involve 370 
specifically increased presence of double-strand DNA damage and senescent cells as well as 371 
accumulation of iron and peroxidation of polyunsaturated fatty acids in CNS cells (Fielder et 372 
al., 2017; Maynard et al., 2015; Sfera et al., 2018). These putative longevity pathways could 373 
shed some light on the molecular basis of homeostatic microglial brain maintenance in long 374 
living animals such as humans. Our analysis additionally revealed that human microglia express 375 
the great majority of genes related to susceptibility to AD and PD (but not to Huntington or 376 
Schizophrenia), whereas rodent microglia only express a fraction of these genes.  377 
 378 
We identify substantial heterogeneity in human microglia as well as a sub-cluster of human 379 
microglia that expressed a complex senescence-associated secretory phenotype (SASP), which 380 
is thought to play a role in homing of immune cells for clearance of senescent cells (Lopes-381 
Paciencia et al., 2019). Regulation of SASP has been linked to several pathways, such as DNA 382 
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damage response and activation of immune response (Ito et al., 2017). As with any studies 383 
involving human tissue, especially the CNS, caution has to be given to the interpretation of the 384 
results. Although we exercised great care and carefully calibrated sample acquisition and 385 
processing time (STAR Methods), it cannot be excluded that patients’ microglia are not 386 
accurately recapitulating the in situ states of healthy brains. Nonetheless, comparable studies 387 
of human and mouse microglia with more extensive disease range (epilepsy, brain tumors, or 388 
acute ischemia) showed very similar results (Gosselin et al., 2017; Masuda et al., 2019). This 389 
supports our argument for human microglia heterogeneity that is not observed to this extent in 390 
other species. In summary, our analysis identifies the microglia gene program across evolution. 391 
It also provides a fundamental resource to compare microglia over a large evolutionary scale 392 
and to guide future development and improvements in understanding of our laboratory models 393 
of diseases mediated by microglia dysfunction.  394 
 395 
 396 
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FIGURE LEGENDS 434 
Figure 1. Quantitative analysis of microglia morphology in evolutionary distant animals. 435 
(A) Phylogenetic tree based on the NCBI taxonomy of animals used in this study (generated 436 
via https://phylot.biobyte.de/). Ma = Million years. (B) Three-dimensional reconstruction (scale 437 
bar represents 20 µm) and Imaris-based automatic quantification (C-G) of cell morphometry 438 
of cortical Iba1+, Mpeg1-eGFP+ (zebrafish) and CSF1R-mApple+ (chicken) microglia. Each 439 
panel displays one individual sample with at least three measured cells per animal. Data are 440 
presented as mean ± SEM. (H) Brain tissue was subjected to immunohistochemistry for Iba1 441 
or stained with antibodies against the respective fluorescent proteins (zebrafish and chicken) to 442 
detect microglia. Scale bar represents 50 µm. Representative images are displayed. (I) Number 443 
of ramified parenchymal microglia in the CNS. (J) Number of cresyl violet+ cortical neurons 444 
in the CNS. (K) Calculated ratio of Neurons per microglia. For (H)-(K), each symbol displays 445 
one individual sample. Three to four sections per sample were analyzed. Data is presented as 446 
mean ± SEM. 447 
 448 
Figure 2. Transcriptional characterization of microglia across species. (A) Illustrative 449 
representation of RNA-seq strategy and cross-species characterization of microglia using flow 450 
cytometry for single cell sort and bulk sort. Some of the examined species are shown as an 451 
example. (B) Metacell analysis (of 629 cells and 22 Metacells) and heat-map representation of 452 
30 differentially expressed genes and marker genes from CD45+ single cell RNA-seq sorted 453 
cells from a chicken brain. (C) Scatter (xy) plot showing the relationship of expressed genes 454 
between all CD45+ genes from combined single cell RNA-seq from chicken (x) and bulk RNA-455 
seq before in silico deconvolution (y). (D) Scatter (xy) plot showing the relationship of 456 
expressed genes between bulk RNA-seq of chicken microglia before deconvolution (x) and 457 
bulk RNA-seq of chicken microglia after deconvolution (y). 458 
 459 
Figure 3. Conserved microglia core gene expression program across evolution. (A) 460 
Heatmap representation of ranked bulk RNA-seq expression of in silico deconvoluted 461 
microglia. Genes are clustered by the most differential gene expression (k-means=17) with 462 
representative dendrogram showing nested groups of microglia genes measured by Pearson’s 463 
correlation coefficient. Annotations of shared and differential profile signature over species 464 
considering top 50% (0.50 percentile) of all genes in the gene-set as a fixed expression threshold 465 
(by row). Non- and lowly expressed genes are in the lowest percentile (0.5-0.67), medium 466 
expressed genes in the mean percentile (0.68-0.85) and highest expressed genes in the top 467 
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percentile (0.86-1.0). Biological replicates; Human microglia (n=6), Marmoset microglia 468 
(n=2), Macaque microglia (n=2), Hamster microglia (n=2), Sheep microglia (n=2), Chicken 469 
(n=2), Zebrafish (n=2), Mouse microglia (One individual from each strain depicted; C57Bl/6, 470 
CD1, Balb/c, FVB, Wild mouse) (B) Bar plots of ranked bulk RNA-seq expression of highly 471 
conserved and highly expressed genes identified in cluster 1 (as shown in A). Genes with no 472 
orthologues are marked with a diagonally striped bar. (C) Violin-plots showing median (black 473 
dot) and distribution of scRNA-seq gene expression (UMI count) across different replicates and 474 
species. (D) Heatmap of mean gene expression of mouse microglia genes in cluster 1 to 3 (left 475 
panel, highly conserved genes) compared to gene sets of mouse tissue macrophages as 476 
described in (Lavin et al., 2014) (right panel). The most differentially expressed genes are 477 
depicted (163 genes out of a total sum of 1791 genes from clusters 1-3).  478 
 479 
Figure 4. Identification of microglia heterogeneity using single cell RNA-seq analysis. (A) 480 
Scatter plot showing the relationship between inter- and intra-cluster correlation (Pearson 481 
correlation rs) of species. (B-C) Cell-to-cell correlation plot of microglia and corresponding 482 
heatmap for most differentially expressed genes. In the heatmap, each mark represents one 483 
metacell and each row marks the metacell from one individual. (B) Human microglia (n=6). 484 
Color-barcoding marks each human individual at the bottom of the respective row. (C) 485 
Microglia from wild mice (n=5). Color barcoding marks each mouse strain analyzed. (D) 486 
Volcano plot showing the most differential genes between homeostatic microglia and microglia 487 
subtypes (Metacells 3-6; p-value < 10-7). Zoom in of specific genes for clarity is shown. (E) 488 
Bar graph showing the contribution of each sample to corresponding gene expression (F) Gene-489 
gene correlation heatmap of senescent-like cluster in human microglia (Metacells 3-6). Red 490 
shows high correlation and blue shows anti-correlation. 491 
 492 
Figure 5. Inter-species comparison of homeostatic microglia uncovers species differences. 493 
(A) Scatter plot showing inter-species microglia gene expression. Gene expression is calculated 494 
as log (sum of UMI)/number of cells. The genes related to the non-homeostatic subtypes of 495 
human microglia (From Figure 4) has been removed from the analysis. A subset of differentially 496 
expressed genes and marker genes are highlighted in red. (B) Spearman correlation of single 497 
cell RNA-seq expression (UMI count) of genes expressed in (from left to right); Alzheimer’s 498 
susceptibility genes (AD), Parkinson’s susceptibility genes (PD), Huntington’s disease (HD), 499 
and Schizophrenia (SCZ). Species from top to bottom; Human vs Macaque, Human vs. 500 
Marmoset, Human vs. Rat, Human vs. Mouse, Human vs. BMR, and Human vs. Hamster (C) 501 
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Violin-plots showing median (black dot) and distribution of single cell RNA-seq gene 502 
expression (UMI count) across different replicates and species.  503 
 504 
STAR METHODS 505 
 506 
CONTACT FOR REAGENT AND RESOURCE SHARING  507 
Further information and requests for reagents should be directed to and will be fulfilled by lead 508 
author Ido Amit (ido.amit@weizmann.ac.il).  509 
EXPERIMENTAL MODEL AND SUBJECT DETAILS  510 
Experimental animals  511 
All experimental procedures were either approved by a local ethical review committee and 512 
conducted in accordance with personal and project licenses under the UK Animals (Scientific 513 
Procedures) Act (1986) or performed in accordance with institutional animal welfare guidelines 514 
and were approved by the government of Baden-Wurttemberg, Germany. Details of 515 
experimental animals can be found in the Supplemental Information.  516 
 517 
Sample processing  518 
Mice, rats, BMR and hamsters were trans-cardially perfused with PBS before tissue extraction 519 
whereas other animals were not perfused due to size limitations. Whole brains (zebrafish, 520 
chicken, hamster, mice, marmoset and macaque), or specific parts of the brain (cortex and white 521 
matter from sheep and human), were collected.  Surrounding human brain tissues (access tissue) 522 
that had to be removed in order to reach the respective putative epileptic focus from individuals 523 
undergoing brain surgery for epilepsy were placed in ice-cold PBS immediately after resection. 524 
Absence of pathology was confirmed by histological analysis in the respective area by a 525 
neuropathologist. In addition, samples from adult patients that underwent brain autopsies were 526 
included if tumor or inflammatory diseases were absent. 527 
METHOD DETAILS 528 
Sample processing for histology and FACS 529 
Single-cell suspensions of tissues for all animals, were achieved using mechanical dissociation, 530 
followed by density gradient separation; Pellet was mixed with 37% percoll (Cat. no. P1644, 531 
Sigma) and centrifuged in 800G for 30 min at 4oC. Supernatant was discarded and pellet was 532 
taken further for antibody staining, as described below. Cell suspension was treated with 1:4000 533 
diluted DAPI solution in 1xPBS to label dead cells. Before proceeding with antibody staining, 534 
cells were pre-incubated with mouse or human Fc receptor blocking antibody (BD Biosciences, 535 
Cat. 553141) for 20 minutes at 4°C. For antibody staining, cells were incubated with antibody 536 
cocktail for 20 minutes at 4°C. For FACS staining and setups, cells were acquired on FACS 537 
Canto, LSRII and LSR Fortessa systems (BD Biosciences) and analyzed with Flowjo software 538 
(TreeStar). 539 
 540 
 541 
Histology  542 
Histology was performed as described recently (Erny et al., 2015). Brains were removed and 543 
fixed in 4% buffered formalin. Then brain tissue was dehydrated and embedded in paraffin. 3 544 
µm thin sections were stained with Iba1 (cat. no. 019-19741, Wako) for all species except leech-545 
specific Iba1 ((Drago et al., 2014) provided by J.V.), anti-GFP (cat. no. A11122, Invitrogen) 546 
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for zebrafish and anti-mCherry (cat. no. ab125096, Abcam) for chicken microglia. In addition, 547 
brain tissue was stained for P2Y12 (cat. no. AS-55043, AnaSpec) or with anti-GFP (cat. no. 548 
A11122, Invitrogen) for zebrafish as well for PU.1 (Cat. no. 2258S, Cell Signaling, zebrafish: 549 
cat. no. ab209983, Abcam) At least 3–4 brain sections per sample were evaluated.  550 
 551 
Three-dimensional reconstruction of microglia.  552 
Reconstruction of microglial cells was performed as described before (Erny at al., 2015). 30-553 
µm parasagittal FFPE sections from adult brain tissue were stained with anti-Iba1 (cat. no. 019-554 
19741, Wako) for all species except leech-specific Iba1 ((Drago et al., 2014) provided by J.V.), 555 
anti-GFP (cat. no. A11122, Invitrogen) for zebrafish and anti-mCherry (cat. no. ab125096, 556 
Abcam) for chicken microglia for 48 h, respectively (dilution 1:500 at 4 °C), followed by Alexa 557 
Fluor 568–conjugated secondary antibody (cat. no. A11011, Life technologies) staining, which 558 
was added at a dilution of 1:500 overnight at 4 °C. Nuclei were counterstained with DAPI. 559 
Imaging was performed on an Olympus Fluoview 1000 confocal laser scanning microscope 560 
(Olympus) using a 20× 0.95 NA objective. Z stacks were done with 1.14-µm steps in z direction, 561 
1,024 × 1,024 pixel resolution were recorded and analyzed using IMARIS software (Bitplane). 562 
At least three cortical cells were reconstructed per analyzed sample. 563 
 564 
Flowcytometry single cell sorting 565 
Cell populations were sorted with MoFlo Astrios (Beckman Coulter) Prior to sorting, all 566 
samples were filtered through a 70-µm nylon mesh (Cat. no. 352350, Corning). Samples were 567 
gated for CD45+ after exclusion of doublets and dead cells. Isolated cells were single cell sorted 568 
into 384-well cell capture plates containing 2 µl of lysis solution and barcoded poly(T) reverse-569 
transcription (RT) primers for single-cell RNA-seq (Keren-Shaul et al., 2019). Immediately 570 
after sorting, each plate was spun down to ensure cell immersion into the lysis solution, snap 571 
frozen on dry ice, and stored at –80°C until processed. 572 
 573 
Flowcytometry bulk cell sorting 574 
Cell populations were sorted with MoFlo Astrios (Beckman Coulter). Prior to sorting, all 575 
samples were filtered through a 70-µm nylon mesh (Cat. no. 352350, Corning). Samples were 576 
gated for CD11b+CD45lo microglia population or GFP+ cells for zebrafish or 577 
CD45+CSF1RmApple+ cells for chicken, after exclusion of doublets. 10,000 cells were sorted 578 
into a low-bind Eppendorf tube containing 40 µl of lysis binding buffer.  Immediately after 579 
sorting, tubes were spun down to ensure cell immersion into the lysis solution, snap frozen on 580 
dry ice, and stored at –80°C until processed. 581 
 582 
AB table 583 
Name Source Catalogue # Secondary 
CD45-PE, non-human primate Miltenyi Biotec 130-091-897  
Mouse anti-chicken Bu-1a/b  Bio-Rad MCA5764 IgG1 
Mouse anti-sheep CD45 Bio-Rad MCA896GA IgG1 
Mouse anti-chicken CD45 APC Southern Biotech 8270-11  
Mouse anti-pig CD45 FITC Bio-Rad MCA1222F  
Marmoset CD45 PE BioLegend 250204  
Alexa Fluor 488 BioLegend  406416 Anti-IgG 
Mouse anti-human CD45 PE BioLegend 304058  
Anti-mouse CD11b eBioscences 17-0112-83  
Mouse FcR blocking antibody BD Biosciences 553141  
Hu FcR Binding blocker eBiosciences 14-9161-73  
Anti-NHP CD45 PE BD Biosciences 552833  
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Anti-Rat CD45 PE BD Biosciences 554888  
Goat polyclonal CD11b antibody Abcam Ab62817 Goat IgG 
Donkey anti-Goat IgG (H+L) APC R&D systems F0108 Anti-goat IgG 
 584 
Massively Parallel Single-Cell RNA-seq Library preparation (MARS-seq2.0) 585 
Single-cell libraries were prepared as previously described (Keren-Shaul, Nature Protocols, 586 
2019). In brief, mRNA from cell sorted into cell capture plates are barcoded and converted into 587 
cDNA and pooled using an automated pipeline. The pooled sample is then linearly amplified 588 
by T7 in vitro transcription, and the resulting RNA is fragmented and converted into a 589 
sequencing-ready library by tagging the samples with pool barcodes and Illumina sequences 590 
during ligation, RT, and PCR. Each pool of cells was tested for library quality and concentration 591 
is assessed as described earlier (Keren-Shaul, Nature Protocols, 2019). 592 
 593 
Bulk RNA-seq library preparation 594 
10,000 cells from each population were sorted into 40 µl of lysis/binding buffer (Invitrogen). 595 
mRNA was captured with 12 µl of Dynabeads oligo(dT) (Invitrogen), washed, and eluted at 596 
85oC with 10 µl of 10 mM Tris-Cl (pH 7.5). We used a derivation of MARS-seq as described 597 
(Keren-Shaul, Nature Protocols, 2019), developed for single-cell RNA-seq to produce 598 
expression libraries with a minimum of three replicates per population. 599 
 600 
Genomes 601 
 Species Built Ensemble 
Human Homo sapiens  hg38 ensemble v95 
Mouse Mus musculus mm10 ensemble v95 
Chicken  Gallus gallus galGal5 ensemble v90 
Marmoset Callithrix jacchus calJac3 ensemble v90 
Macaque Macaca fascicularis Mmul 8.0.1 ensemble v90 
Sheep Ovis aries Oar v3.1 ensemble v90 
Zebrafish Danio rerio danRer10 ensemble v90 
Hamster Mesocricetus auratus MesAur1.0 ensemble v90 
Rat Rattus norvegicus Rnor 6.0 ensemble v95 
Blind Mole Rat Nannospalax galili S.galili v1.0 ensemble v96 
 602 
Bulk low-level processing and filtering 603 
Mapping of reads was done using HISAT (version 0.1.6) (Kim et al., 2015). UMIs were filtered 604 
if two reads with matching UMIs were mapped to the same genome position (<3kb distance). 605 
Reads were associated with genes if they were mapped to an exon in the correct orientation of 606 
the gene. Gene expression tables were created using analyzeRepeats.pl script from the HOMER 607 
package (v4.8) giving the specie specific GTF file (-gff flag) and genome from ensembl as 608 
input. (http://homer.ucsd.edu/homer/) 609 
 610 
Ortholog gene selection 611 
To compare between species, we first created a gene ortholog table using the mouse genome as 612 
the reference gene list. We performed gene homology search, using ensemble multiple species 613 
comparison tool (http://www.ensembl.org/biomart/martview). Briefly, each specie was 614 
compared to mouse and high-quality orthologues genes list was extracted (gene order 615 
conservation score above 75, whole genome alignment score above 75 and minimum sequence 616 
identity above 80%). To account for gene paralogues and gene-duplication events, an 617 
aggregated table of “meta-genes” was created. Each meta-gene may include all gene symbols 618 
homologous to one mouse gene. For each organism, read counts were aggregated across all 619 
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manifestations of each meta-gene. (For example, if zebrafish’s actb1 had 2 read, and actb2 3 620 
read, the Actb meta-gene received 5 total reads). Missing genes in species were given NaN 621 
value. 622 
 623 
Deconvolution of bulk data by detecting single cell outliers 624 
Bulk RNA-seq data can contain combination of cell types due to sample acquisition impurity 625 
and existence of outlier cells. Single-cell data was used to clean up bulk samples in the 626 
following approach: Single-cell data from each organism was clustered using the Metacell 627 
package (Baran et al., 2018). Clusters were manually annotated as microglia or outlier cell 628 
types, based on expression of core genes shared by all species. Each bulk sample can be 629 
described as a linear combination of all the cell types included in the samples. Using 630 
optimization algorithms, “L-BFGS-B” in R general-purpose function “optim”, we computed 631 
the contribution of contaminating Metacells. Then, we deconvoluted each bulk sample by 632 
subtracting the relative contribution of the outlier clusters. 633 
 634 
Bulk normalization 635 
Comparing RNA-seq data between species is challenging as the total number of genes differ, 636 
there are large differences in total read number, housekeeping genes expression profile changed 637 
across evolution and many other factors effects conventual RNA-seq normalization methods. 638 
To overcome this technical challenge, we decided to use gene-rank score instead of actual read 639 
count (such as TPM/RPKM). All values in all species were ranked, based on their expression 640 
value position, this ranked vector was used as transcription profile for all downstream analysis. 641 
To discard lowly expressed genes, rank levels were floored to 0.5. Only genes with at least one 642 
entry ranked higher than 0.8 were included in later. Overall, ~9k genes were used for clustering 643 
(Figure 3A).  644 
 645 
Bulk clustering 646 
Ranked bulk RNA-seq data was cluster using the K-means algorithm (Matlab R2018a function 647 
kmeans). The value of k was chosen by assessing the mean silhouette values (a measure of how 648 
close each point in one cluster is to points in the neighboring clusters) for various k parameters 649 
and selecting k that maximizes the average silhouette.  650 
 651 
Single cells low-level processing and filtering 652 
All RNA-Seq libraries were sequenced using Illumina NextSeq 500 at a median sequencing 653 
depth of: human 39032, mouse 47777, zebrafish 31764, chicken 63187, marmoset 57111, 654 
macaque 43212, sheep 47170, hamster 55582, rat 18633, Blind mole rat 11679 reads per single 655 
cell. Detailed statistics in cell resolution on barcodes, reads, mapping and genes see Table S1. 656 
Sequences were mapped to appropriate genome, demultiplexed, and filtered as previously 657 
described (Jaitin et al., 2014), extracting a set of unique molecular identifiers (UMI) that define 658 
distinct transcripts in single cells for further processing. We estimated the level of spurious 659 
UMIs in the data using statistics on empty MARS-seq wells. Mapping of reads was done using 660 
HISAT (version 0.1.6) (Kim et al., 2015); reads with multiple mapping positions were 661 
excluded. Reads were associated with genes if they were mapped to an exon, using the 662 
appropriate ensemble v90 reference genome. Exons of different genes that shared genomic 663 
position on the same strand were considered a single gene with a concatenated gene symbol. 664 
Cells with less than 500 UMIs were discarded from the analysis. All downstream analysis was 665 
performed in R. 666 
 667 
Single cells data processing and clustering 668 
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The Metacell pipeline (Giladi et al., 2018) was used to derive informative genes and compute 669 
cell-to-cell similarity, to compute K-nn graph covers and derive a distribution of RNA in 670 
cohesive groups of cells (or meta-cells), and to derive strongly separated clusters using 671 
bootstrap analysis and computation of graph covers on resampled data. Default parameters were 672 
used unless otherwise stated. 673 
 674 
Clustering of cells was performed for FACS sorted cells. Cells with high (> 32) expression of 675 
hemoglobin genes were discarded (HBB, HBA1, HBA2). UMI was filtered out of ERCC reads. 676 
Mitochondrial genes and ribosomal genes were removed from the analysis. Cells with limit of 677 
UMI count after all filtering was >500. We used bootstrapping to derive robust clustering (500 678 
iterations; resampling 70% of the cells in each iteration, and clustering the co-cluster matrix 679 
with minimal cluster size set to 20). No further filtering or cluster splitting was performed on 680 
the meta-cells.  681 
 682 
Gene enrichment analysis 683 
We performed gene enrichment analysis of human specific cluster and the large mammals 684 
cluster (cluster 11 and 12 of figure 3A clustering analysis) using the online Metascape 685 
(http://metascape.org/) tool with default parameters, using all genes as background. Genes from 686 
human senescent-like microglia cell cluster has been removed from the analysis. For gene 687 
related to neurodegenerative diseases enrichment we used GWAS gene lists from the NHGRI-688 
EBI GWAS catalog (mapped to Genome Assembly GRCh38.p12 and dbSNP Build 151) and 689 
perform hypergeometric distribution test for each cluster from figure 3A, p<0.01 was 690 
considered significant. 691 
 692 
Single cells differential expression 693 
To compare single cell expression between species, UMI tables were transformed to meta-genes 694 
as described above. For each organism, we used meta-cell clustering to discard outlier cells and 695 
activated microglia. Each cell was normalized by cell size and log transformed. We tested for 696 
significantly differential genes by FDR adjusted Wilcoxon test (p-value < 10-10 and fold change 697 
> 2). 698 
 699 
Bulk of Single cell 700 
Single cell UMI cells loaded as in Single cells differential expression test. All good cells UMI 701 
was summed which resulted in a single column for each organism. The small table of single 702 
column for each organism was normalized to same number of reads. 703 
 704 
Scatter plots 705 
Bulked single cell gene list was used. All genes from microglia core gene module (Figure 3A) 706 
were plotted unless a gene was not existing in one of the two species.  707 
 708 
PCA 709 
PCA was done in (Matlab R2018a function PPCA) (Verbeek et al., 2002) based on sensible 710 
principal components analysis. 711 
 712 
Defining a module gene signature  713 
To define a module gene signature for Metacells 3-6 of the human microglia (Figure 4), we 714 
used the normalized UMI table to identify the most differential genes between our clusters and 715 
identified a group of 26 genes (e.g. Cdkn1, Ccl2, Tnf) that exhibited a strong Pearson correlation 716 
across the Metacells’ log2 footprint expression of the 200 most variable genes excluding genes 717 
associated with mitochondria and stress that were filtered from these lists in advance. The p-718 
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value was calculated using Wilcoxon signed-rank test and false discovery rate (FDR) 719 
correction. The threshold for differential genes was set at pValue < 1E-7. 720 
 721 
DATA AND SOFTWARE AVAILABILITY  722 
The accession number for the raw sequence reported in this paper is EGA: The accession 723 
number for the processed data reported in this paper is NCBI GEO: GSE134707. Scripts 724 
reproducing the analysis will be available at: https://bitbucket.org/amitlab/.  725 
 726 
SUPPLEMENTARY FIGURE LEGENDS 727 
Figure S1. Related to Figure 1. (A) Representative reconstructed ramified parenchymal 728 
microglia cells and corresponding fluorescence images of Iba1+, Mpeg1-eGFP+ (zebrafish) and 729 
CSF1R-mApple+ (chicken) microglia (red) and DAPI (4′,6-diamidino-2-phenylindole, blue) 730 
from all analyzed species. Scale bar represents 20 µm. (B) Three-dimensional reconstruction 731 
(scale bar represents 10 µm) and Imaris-based automatic quantification (C) of cell 732 
morphometry of cortical mouse and human Iba1+ microglia from different brain regions (cortex, 733 
cerebellum, hippocampus and white matter). Each symbol displays one individual sample with 734 
at least three measured cells per animal. Data is presented as mean ± SEM Spearman correlation 735 
analysis comparing (C) microglial per mm² and microglia process length, (D) microglia per 736 
mm² and neurons per mm² and (E) microglia per 100 neurons ratio and microglia process 737 
length.  738 
 739 
Figure S2. Related to Figure 1. Quantitative assessment of mouse and human microglia and 740 
neurons in different brain regions. Iba1+ microglia and cresyl violet+ neurons in the mouse and 741 
human frontal cortex (A), cerebellum (B), hippocampus (C) and white matter (D) (left) and 742 
quantification thereof (right). Scale bar represent 50 µm for Iba1 and 200, 100 or 50 µm for 743 
cresyl violet. Each symbol displays one individual sample. Data is presented as mean ± SEM 744 
Significant differences were determined by an unpaired t-test and marked with asterisks (**P 745 
< 0.01, ***P < 0.001).  746 
 747 
Figure S3. Related to Figure 2. (A) Representative flow cytometric plots showing gating 748 
strategy for brain CD45+ single-cell RNA sequencing sort. (B) Total UMI/cell count per 749 
plate/animal. (C) UMI/cell count after filtering for microglia. (D) Percentage of microglia 750 
identified in each species from flow cytometry sorted brain CD45+ single cells. (E) Scatter (xy) 751 
plot showing the relationship of expressed genes between single cell RNA-seq of chicken 752 
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microglia based on Figure 2B cluster (x) and bulk RNA-seq of chicken microglia after 753 
deconvolution (y). 754 
 755 
Figure S4. Related to Figure 3. (A) Heatmap representation of an average of single-cell RNA-756 
seq expression (UMIs per cell/number of cells) of microglia across species (row). Clustering of 757 
most differentiated genes (k=17). (B) Principal component analysis (PCA) plot of all genes 758 
from all species and their biological replicates. (C) Bar plots of ranked bulk RNA-seq 759 
expression of representative highly conserved and highly expressed genes identified from 760 
clusters 1-3 (as shown in Fig. 3A). Error bars show standard deviation (SD). Genes with no 761 
orthologues are marked with a diagonally striped bar. (D-E) Correlation of global expression 762 
signature of microglia across species measured by Spearman rank correlation (rs) (D) of single 763 
cell RNA-seq from all species (E) of bulk RNA-seq of microglia of species. Significant 764 
biological processes or pathways identified using Metascape software analysis of (F) all genes 765 
from clusters 1-3 using all genes as a background or (G) microglia specific genes identified in 766 
a comparative analysis of tissue macrophages and microglia in Fig. 3D, using all genes as a 767 
background.  768 
 769 
Figure S5. Related to Figure 3. (A) Representative P2Y12 immunohistochemistry 770 
microscopical images from paraffin brain sections from human, macaque, marmoset, mouse, 771 
sheep, boar or bat as well as representative immunofluorescence image from brain section from 772 
zebrafish. Scale bar represents 100 µm or 25 µm (zebrafish). (B) Representative PU.1 773 
immunohistochemistry microscopical images from paraffin brain sections from human, 774 
macaque, marmoset, mouse, sheep or zebrafish. Scale bars represents 100 µm. 775 
 776 
 Figure S6. Related to Figure 4. (A-F) Cell-to-cell correlation plots of microglia and 777 
corresponding heatmaps for most differentially expressed genes. In the heatmaps, each mark 778 
represents one cell and each row the cells from one individual. (A) Marmoset microglia (n=5). 779 
(B) Macaque microglia (n=5). (C) Hamster microglia (n=5). (D) Sheep microglia (n=5)                           780 
(E) Wild mouse microglia (n=5). (F) A tSNE plot showing five mouse strains: C57BL/6, 781 
Balb/c, CD1, FVB and Wild mice (n=5, each strain). (G) A tSNE plot of the most differentiated 782 
marker genes expressed in mouse strains. The intensity of color corresponds to increased 783 
expression. (H) A x-y plot comparing bulk RNA-seq of wild mouse microglia with averaged 784 
bulk RNA-seq expression of mouse strains in SPF conditions (C57BL/6, CD1, Balb/c, FVB). 785 
The most significant genes (Wild vs. SPF averaged) are labeled.  786 
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 787 
Figure S7. Related to Figure 5. (A-B) Heatmap representation and clustering of most 788 
differentiated genes (k=12) of (A) a deconvoluted bulk of microglia and (B) an average of 789 
single-cell RNA-seq expression (UMIs per cell/number of cells) of microglia across species 790 
(row). (C) x-y plots comparing bulked single cell RNA-seq of rodents to each other. Highest 791 
differentially expressed genes are demonstrated. (D) Gene ontology (GO) terms enriched in 792 
human, macaque, marmoset and sheep microglia (cluster 11; Figure 3A). Differential genes 793 
from human senescent-like microglia has been removed from the analysis.  (E) Gene ontology 794 
(GO) terms enriched in homeostatic human microglia (cluster 8; Figure S7A). Differential 795 
genes from human senescent-like microglia were removed from the analysis. (F-H) Heatmap 796 
representations of Gene ontology (GO) terms enriched in clusters related to Figure S7A. Genes 797 
from human senescent microglia cell cluster were removed from the analysis. Highest 798 
significantly enriched pathways in homeostatic human microglia (cluster 8) are represented. 799 
(F) Specific genes from the classical complement pathway (GO: 0006956). (G) Specific genes 800 
from apoptotic cell clearance (GO: 0043277). (H) Specific genes from ferroptosis pathway 801 
(GO: 0097). Grey boxes indicate non-orthologue.  802 
 803 
 Figure S8. Related to Figure 5. (A-D) Clusters identified from cross-species comparison of 804 
microglia (from Figure 3A) and visual demonstration of enrichment of GWAS terms shown as 805 
fold change per cluster. Hypergeometric test was used to calculate the statistical significance 806 
of under- or over-representation of a module of genes in clusters. Significantly enriched GWAS 807 
gene lists (p = 0.001) are marked with an asterisk (*). Human clusters are colored in pink; 808 
mouse clusters are colored in light blue. (E-F) Heatmap of gene expression of specific 809 
neurodegenerative diseases defined by published GWAS from the NHGRI-EBI GWAS catalog 810 
(mapped to Genome Assembly GRCh38.p12 and dbSNP Build 151). Genes that are specifically 811 
absent or lowly expressed in mouse but not in humans are demonstrated. Grey boxes indicate 812 
there is no homologous gene. (G) Violin-plots of specific genes related to specific 813 
neurodegenerative diseases defined by published GWAS as in panels E to F. 814 
 815 
SUPPLEMENTARY TABLE LEGENDS 816 
Table S1. Sample information. Related to Figure 1-2. 817 
Table S2. Differential gene expression analysis of cross-species comparison of ranked 818 
expression values of microglia genes. Related to Figure 3. First tab includes all animals while 819 
the second tab includes only the mammalian orthologs.  820 
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Table S3. Pearson correlation of deconvoluted bulk microglia. Related to Figure S4D. 821 
Pearson correlation of ranked gene expression values of microglia.  822 
Table S4. Comparison of highly conserved microglia genes to tissue macrophage genes. 823 
Related to Figure 3 and Table S2. Highly expressed and conserved microglia genes from 824 
cluster 1-3 (Figure 3; Table S2) compared to gene sets of mouse tissue macrophages as 825 
described in (Lavin et al., 2014). The most differentially expressed genes are depicted (163 826 
genes out of a total sum of 1791 genes from clusters 1-3 827 
Table S5. Pairwise comparison of human vs. other mammals, related to Figure 5 and S7. 828 
Most differential genes between human and the most common mammalian animal models. 829 
Table S6. Pathway analysis of clusters related to Figure 3 and Table S2. RNA-seq gene 830 
expression of specific pathways defined by Gene ontology (GO) terms  831 
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